alfuzosin has been researched along with Dermatomyositis in 2 studies
alfuzosin: structure given in first source
Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vela-Casasempere, P | 1 |
Borras-Blasco, J | 1 |
Navarro-Ruiz, A | 1 |
Navarro-Blasco, FJ | 1 |
2 other studies available for alfuzosin and Dermatomyositis
Article | Year |
---|---|
Alfuzosin-associated dermatomyositis.
Topics: Adrenergic alpha-Antagonists; Aged; Dermatomyositis; Humans; Magnetic Resonance Imaging; Male; Muscl | 1998 |
Alfuzosin is not associated with dermatomyositis.
Topics: Adrenergic alpha-Antagonists; Carcinoma; Dermatomyositis; Humans; Lung Neoplasms; Male; Quinazolines | 1999 |